Latest revenue
$73.7M
as of 2026-03-31
Latest net income
$-101.9M
as of 2026-03-31
Net margin
-138.2%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $10.56B
- Enterprise value
- $10.56B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $82.26
- 52-wk low
- $14.30
- Beta
- —
- Shares out
- 140.9M
5-year trend
About ARWR
Business description and risk factors will appear here once ARWR's latest filing is fully ingested.
Profitability
Operating margin
11.9%
100.1%Net margin
-0.2%
100.0%Return on equity
-0.3%
99.9%Return on assets
-0.1%
99.8%Leverage
Debt / equity
1.97×
61.7%Long-term debt / equity
0.46×
78.3%Debt / assets
66.4%
20.7%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $73.7M | -86.4% | $-101.9M | -151.6% | -138.2% |
Q4 2025 2025-12-31 | $264.0M | +10461.3% | $30.8M | +117.8% | 11.7% |
Q3 2025 2025-09-30 | $256.5M | — | $-48.0M | +71.8% | -18.7% |
Q2 2025 2025-06-30 | $27.8M | — | $22.1M | +113.0% | 79.7% |
Q1 2025 2025-03-31 | $542.7M | — | $197.4M | +257.5% | 36.4% |
Q4 2024 2024-12-31 | $2.5M | -29.6% | $-173.1M | -30.3% | -6923.4% |
Q3 2024 2024-09-30 | $0 | — | $-170.5M | — | — |
Q2 2024 2024-06-30 | $0 | -100.0% | $-170.8M | -78.7% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Pharmaceutical Preparations · SIC 2834
Your notes
Keep private notes on ARWR — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$37.9M
Net activity
−$37.9M
Distinct insiders
10
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ARWR
Institutional value
$3.47B
Total shares held
56.0M
Distinct holders
266
-132 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 18.2M | $1.14B | -3.2M (-14.8%) | Trimmed |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.1M | $448.1M | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | $378.2M | — | New |
| 4 | Invesco Ltd. | 3.3M | $205.7M | +2.7M (+498.9%) | Added |
| 5 | UBS Group AG | 1.3M | $83.8M | +349.0K (+35.3%) | Added |
| 6 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.3M | $83.5M | +70.6K (+5.6%) | Added |
| 7 | Pictet Asset Management Holding SA | 1.3M | $79.6M | +244.5K (+23.8%) | Added |
| 8 | Fisher Asset Management, LLC | 1.1M | $69.8M | -198.2K (-15.1%) | Trimmed |
| 9 | VANGUARD FIDUCIARY TRUST CO | 965.8K | $60.6M | — | New |
| 10 | Bank of New York Mellon Corp | 960.1K | $60.2M | +72.3K (+8.1%) | Added |
| 11 | Connor, Clark & Lunn Investment Management Ltd. | 837.0K | $52.5M | +173.7K (+26.2%) | Added |
| 12 | Western Financial Corp/CA | 820.2K | $51.4M | +0 (+0.0%) | No change |
| 13 | Voya Investment Management LLC | 656.1K | $41.1M | +233.4K (+55.2%) | Added |
| 14 | BNP PARIBAS FINANCIAL MARKETS | 650.6K | $40.8M | +610.2K (+1510.5%) | Added |
| 15 | JPMORGAN CHASE & CO | 683.1K | $39.4M | +71.2K (+11.6%) | Added |
| 16 | DIMENSIONAL FUND ADVISORS LP | 608.5K | $38.1M | +461.1K (+312.8%) | Added |
| 17 | Nuveen, LLC | 499.8K | $31.3M | +211.3K (+73.2%) | Added |
| 18 | PRINCIPAL FINANCIAL GROUP INC | 490.1K | $30.7M | -225.4K (-31.5%) | Trimmed |
| 19 | FRANKLIN RESOURCES INC | 462.7K | $29.0M | +355.3K (+331.0%) | Added |
| 20 | RHUMBLINE ADVISERS | 404.4K | $25.4M | +52.0K (+14.8%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ARWR's latest filing finishes processing.